Cdc 12413 DS1.Pdf
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Section 8: Hematology CHAPTER 47: ANEMIA
Section 8: Hematology CHAPTER 47: ANEMIA Q.1. A 56-year-old man presents with symptoms of severe dyspnea on exertion and fatigue. His laboratory values are as follows: Hemoglobin 6.0 g/dL (normal: 12–15 g/dL) Hematocrit 18% (normal: 36%–46%) RBC count 2 million/L (normal: 4–5.2 million/L) Reticulocyte count 3% (normal: 0.5%–1.5%) Which of the following caused this man’s anemia? A. Decreased red cell production B. Increased red cell destruction C. Acute blood loss (hemorrhage) D. There is insufficient information to make a determination Answer: A. This man presents with anemia and an elevated reticulocyte count which seems to suggest a hemolytic process. His reticulocyte count, however, has not been corrected for the degree of anemia he displays. This can be done by calculating his corrected reticulocyte count ([3% × (18%/45%)] = 1.2%), which is less than 2 and thus suggestive of a hypoproliferative process (decreased red cell production). Q.2. A 25-year-old man with pancytopenia undergoes bone marrow aspiration and biopsy, which reveals profound hypocellularity and virtual absence of hematopoietic cells. Cytogenetic analysis of the bone marrow does not reveal any abnormalities. Despite red blood cell and platelet transfusions, his pancytopenia worsens. Histocompatibility testing of his only sister fails to reveal a match. What would be the most appropriate course of therapy? A. Antithymocyte globulin, cyclosporine, and prednisone B. Prednisone alone C. Supportive therapy with chronic blood and platelet transfusions only D. Methotrexate and prednisone E. Bone marrow transplant Answer: A. Although supportive care with transfusions is necessary for treating this patient with aplastic anemia, most cases are not self-limited. -
Tareq Al-Adaily Ibrahim Elhaj Ayah Fraihat Dana Alnasra Sheet
Anemia of decreased production II Sheet 3 – + Hemolytic anemia Dana Alnasra Ayah Fraihat Ibrahim Elhaj Tareq Al-adaily 0 **Flashback to previous lectures: − Anemia is the reduction of oxygen carrying capacity of blood secondary to a decrease in red cell mass. − We classified anemia according to cause into: 1. Anemia of blood loss (chronic and acute) 2. Anemia of decreased production 3. Hemolytic anemia − Then, we mentioned general causes for the anemia of decreased production, which are: nutritional deficiency, chronic inflammation, and bone marrow failure. We’ve already discussed the first two and now we will proceed to the last one. Anemias resulting from bone marrow failure: 1. Aplastic anemia 2. Pure red cell aplasia 3. Myelophthisic anemia 4. Myelodysplastic syndrome Other anemias of decreased production: 1. Anemia of renal failure 2. Anemia of liver disease 3. Anemia of hypothyroidism 00:00 1. Aplastic anemia Is a condition where the multipotent myeloid stem cells produced by the bone marrow are damaged. Remember: the bone marrow has stem cells called myeloid stem cells which eventually differentiate into erythrocytes, megakaryocytes (platelets), and myeloblasts (white blood cells). Notice that lymphocytes are not produced from the myeloid progenitor, therefore, they are not affected. depleted normal 1 | P a g e As a result, the bone marrow becomes depleted of hematopoietic cells. And this is reflected as peripheral blood pancytopenia (all blood cells -including reticulocytes- are decreased, with the exception of lymphocytes). Pathogenesis There are two forms of aplastic anemia according to pathogenesis: a. Acquired aplastic anemia It happens because of an extrinsic factor e.g. -
A Case of Hemolysis and Methemoglobinemia Following Amyl Nitrite Use in an Individual with G6PD Deficiency
Available online at www.sciencedirect.com Journal of Acute Medicine 3 (2013) 23e25 www.e-jacme.com Case Report A case of hemolysis and methemoglobinemia following amyl nitrite use in an individual with G6PD deficiency Anselm Wong*, Zeff Koutsogiannis, Shaun Greene, Shona McIntyre Victorian Poisons Information Centre, Austin Hospital, Heidelberg 3084, Victoria, Australia Received 28 August 2012; accepted 26 December 2012 Available online 5 March 2013 Abstract A 34-year-old man presented feeling generally unwell with dark urine 3 days after inhaling amyl nitrite. His initial heart rate was 118/min, blood pressure 130/85 mmHg, O2 saturation 85% on 15 L/min oxygen, and Glasgow coma score 15. He was pale, with clear chest sounds on auscultation. His hemoglobin was 60 g/L, bilirubin 112 mM, and methemoglobin concentration 6.9% on an arterial blood gas. Amyl nitrite- induced hemolysis and methemoglobinemia were diagnosed. Methylene blue was not administered because of the relatively low methemo- globin concentration and the possibility of inducing further hemolysis. He was subsequently confirmed as having glucose-6-phosphate dehy- drogenase deficiency, which had originally been diagnosed in childhood. Amyl nitrite toxicity may include concurrent methemoglobinemia and hemolysis. Administration of methylene blue for clinically significant methemoglobinemia can induce further hemolysis. Copyright Ó 2013, Taiwan Society of Emergency Medicine. Published by Elsevier Taiwan LLC. All rights reserved. Keywords: Amyl nitrite; Glucose-6-phosphate dehydrogenase deficiency; Hematology; Toxicology 1. Introduction dark urine for 3 days following his return from Vanuatu 4 weeks earlier. He had drunk 100 half-coconut shells of kava Amyl nitrite is one of a number of alkyl nitrites otherwise while there. -
Approach to Anemia
APPROACH TO ANEMIA Mahsa Mohebtash, MD Medstar Union Memorial Hospital Definition of Anemia • Reduced red blood mass • RBC measurements: RBC mass, Hgb, Hct or RBC count • Hgb, Hct and RBC count typically decrease in parallel except in severe microcytosis (like thalassemia) Normal Range of Hgb/Hct • NL range: many different values: • 2 SD below mean: < Hgb13.5 or Hct 41 in men and Hgb 12 or Hct of 36 in women • WHO: Hgb: <13 in men, <12 in women • Revised WHO/NCI: Hgb <14 in men, <12 in women • Scrpps-Kaiser based on race and age: based on 5th percentiles of the population in question • African-Americans: Hgb 0.5-1 lower than Caucasians Approach to Anemia • Setting: • Acute vs chronic • Isolated vs combined with leukopenia/thrombocytopenia • Pathophysiologic approach • Morphologic approach Reticulocytes • Reticulocytes life span: 3 days in bone marrow and 1 day in peripheral blood • Mature RBC life span: 110-120 days • 1% of RBCs are removed from circulation each day • Reticulocyte production index (RPI): Reticulocytes (percent) x (HCT ÷ 45) x (1 ÷ RMT): • <2 low Pathophysiologic approach • Decreased RBC production • Reduced effective production of red cells: low retic production index • Destruction of red cell precursors in marrow (ineffective erythropoiesis) • Increased RBC destruction • Blood loss Reduced RBC precursors • Low retic production index • Lack of nutrients (B12, Fe) • Bone marrow disorder => reduced RBC precursors (aplastic anemia, pure RBC aplasia, marrow infiltration) • Bone marrow suppression (drugs, chemotherapy, radiation) -
Chapter 03- Diseases of the Blood and Certain Disorders Involving The
Chapter 3 Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50- D89) Excludes2: autoimmune disease (systemic) NOS (M35.9) certain conditions originating in the perinatal period (P00-P96) complications of pregnancy, childbirth and the puerperium (O00-O9A) congenital malformations, deformations and chromosomal abnormalities (Q00-Q99) endocrine, nutritional and metabolic diseases (E00-E88) human immunodeficiency virus [HIV] disease (B20) injury, poisoning and certain other consequences of external causes (S00-T88) neoplasms (C00-D49) symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94) This chapter contains the following blocks: D50-D53 Nutritional anemias D55-D59 Hemolytic anemias D60-D64 Aplastic and other anemias and other bone marrow failure syndromes D65-D69 Coagulation defects, purpura and other hemorrhagic conditions D70-D77 Other disorders of blood and blood-forming organs D78 Intraoperative and postprocedural complications of the spleen D80-D89 Certain disorders involving the immune mechanism Nutritional anemias (D50-D53) D50 Iron deficiency anemia Includes: asiderotic anemia hypochromic anemia D50.0 Iron deficiency anemia secondary to blood loss (chronic) Posthemorrhagic anemia (chronic) Excludes1: acute posthemorrhagic anemia (D62) congenital anemia from fetal blood loss (P61.3) D50.1 Sideropenic dysphagia Kelly-Paterson syndrome Plummer-Vinson syndrome D50.8 Other iron deficiency anemias Iron deficiency anemia due to inadequate dietary -
Erythrocytes (Red Blood Cells, Rbcs)
Med Chem 535 ~ Diagnostic Medicinal Chemistry Hematology ~ Erythrocytes (Red Blood Cells, RBCs) I. Tests A. Red Blood Cell Count (RBC)* B. Hemoblobin (Hb or Hgb)* C. Hematocrit (Hct)* D. Wintrobe Indices (Indices) 1. Mean Corpuscular Volume (MCV) 2. Mean Corpuscular Hemoglobin (MCH) 3. Mean Corpuscular Hemoglobin Concentration (MCHC) E. Red Cell Distribution Width (RDW) F. Reticulocyte Count (Retics)* G. Erythrocyte Sedimentation Rate (ESR or Sed Rate) H. Serum Ferritin I. Transferrin and Serum Iron J. Haptoglobin K. Zinc Protoporphyrin Hemoglobin (ZPPH) II. RBC Disorders A. Polycythemia B. Anemias 1. Acute Blood Loss 2. Hemolytic Anemia 3. Anemia of Chronic Disease 4. Nutritional C. Hemoglobinopathies 1. Sickle Cell Anemia 2. Thalassemia 3. Methemoglobinemia/G6PD Deficiency III. Drug Induced Anemia A. Drug-Induced Oxidative Stress B. Cyanide Poisoning C. Immune Hemolytic Anemia HEMATOLOGY ~ ERYTHROCYTES HEMATOLOGY ~ the study of blood and its cellular elements: Erythrocytes (a.k.a., red blood cells), Leukocytes (a.k.a., white blood cells), and Platelets. The bone marrow typically produces ~ 2.5 x 109 RBCs, 1 x 109 granulocytes and 2.5 x 109 platelets per kg/day. CBC ~ Complete Blood Count is one of the most commonly ordered lab tests. It typically includes an erythrocyte count (RBC), leukocyte count (WBC), hemoglobin concentraton (Hgb), hematocrit (Hct), RBC indices, reticulocyte count, and platelet count. When a CBC with differential (Dif) is ordered, the WBC subtypes are quantified. Absolute Neutrophil Count (ANC) ~ neutrophil absolute number vs. relative percent Flow Cytometry Instruments can count 50,000 cells/sec When a particle passes through the detector it scatters light. Forward scattering is proportional to the size of the particle (cell): Particles between 2 fL and 20 fL are platelets; Particles > 36 fL are RBCs and WBCs; Analysis of samples with lysed RBCs affords WBCs. -
Anemia in Children JOSEPH J
Anemia in Children JOSEPH J. IRWIN, M.D., and JEFFREY T. KIRCHNER, D.O., Lancaster General Hospital, Lancaster, Pennsylvania Anemia in children is commonly encountered by the family physician. Multiple causes exist, but with a thorough history, a physical examination and limited laboratory evaluation a specific diagnosis can usually be established. The use of the mean corpuscular volume to classify the ane- mia as microcytic, normocytic or macrocytic is a standard diagnostic approach. The most common form of microcytic anemia is iron deficiency caused by reduced dietary intake. It is easily treat- able with supplemental iron and early intervention may prevent later loss of cognitive function. Less common causes of microcytosis are thalassemia and lead poisoning. Normocytic anemia has many causes, making the diagnosis more difficult. The reticulocyte count will help narrow the differential diagnosis; however, additional testing may be necessary to rule out hemolysis, hemoglobinopathies, membrane defects and enzymopathies. Macrocytic anemia may be caused by a deficiency of folic acid and/or vitamin B12, hypothyroidism and liver disease. This form of anemia is uncommon in children. (Am Fam Physician 2001;64:1379-86.) nemia is a frequent laboratory in developing humans: the embryonic, abnormality in children. As Gower-I, Gower-II, Portland, fetal hemoglo- many as 20 percent of children bin (HbF) and normal adult hemoglobin in the United States and 80 per- (HbA and HbA2). HbF is the primary hemo- cent of children in developing globin found in the fetus. It has a higher affin- Acountries will be anemic at some point by the ity for oxygen than adult hemoglobin, thus age of 18 years.1 increasing the efficiency of oxygen transfer to the fetus. -
Table of Contents
Table of Contents 09.06.02 - RULES GOVERNING MINIMUM MEDICAL\ AND HEALTH STANDARDS FOR PAID FIREMEN 000. LEGAL AUTHORITY. ........................................................................................ 3 001. TITLE AND SCOPE. ......................................................................................... 3 002. WRITTEN INTERPRETATIONS. ...................................................................... 3 003 ADMINISTRATIVE APPEALS. .......................................................................... 3 004.-- 010. (RESERVED). ......................................................................................... 3 Archive011. MINIMUM MEDICAL AND HEALTH STANDARDS FOR PAID FIREMEN. ...... 3 012. ABDOMINAL ORGANS AND GASTROINTESTINAL SYSTEM. ...................... 3 013. BLOOD AND BLOOD-FORMING TISSUE DISEASES. ................................... 4 014. DENTAL. .......................................................................................................... 5 015. EARS. ............................................................................................................... 6 016. HEARING. ......................................................................................................... 6 017. ENDOCRINE AND METABOLIC DISORDERS. ............................................... 7 018. UPPER EXTREMITIES. .................................................................................... 7 019. LOWER EXTREMITIES. .................................................................................. -
Anemia LECTURE in INTERNAL MEDICINE for IV COURSE
Anemias in the mirror of the real clinical cases LECTURE IN INTERNAL MEDICINE FOR IV COURSE STUDENTS M. Yabluchansky, L. Bogun, L. Martymianova, O. Bychkova, N. Lysenko, M. Brynza V.N. Karazin National University Medical School’ Internal Medicine Dept. Plan of the lecture • Definition • Epidemiology • Etiology & Mechanisms • Adaptation to anaemia • Classification • Clinical investigation • Diagnosis • Treatment • Prognosis • Prophylaxis • Abbreviations • Diagnostic guidelines http://anemiaofchronicdisease.com/wp-content/uploads/2012/08/anemia-of-chronic-disease1.jpg Definition Anemia is a disease and/or a clinical syndrome that consist in lowered ability of the blood to carry oxygen (hypoxia) due to decrease quantity and functional capacity and/or structural disturbances of red blood cells (RBCs) or decrease hemoglobin concentration or hematocrit in the blood A severe form of anemia, in which the hematocrit is below 10%, is called the hyperanemia WHO criteria is Hb < 13 g/dL in men and Hb < 12 g/dL in women (revised criteria for patient’s with malignancy Hb < 14 g/dL in men and Hb < 12g/dL in women) Epidemiology 1 https://www.k4health.org/sites/default/files/anemia-map_updated.png Epidemiology 2 http://img.medscape.com/fullsize/migrated/editorial/conferences/2006/4839/spivak.fig1.jpg Etiology & Mechanisms 1 (basic forms) Basic forms • Blood loss • Deficient erythropoiesis • Excessive hemolysis (RBC destruction) • Fluid overload (hypervolemia) http://www.merckmanuals.com/professional/hematology-and-oncology/approach-to-the-patient-with-anemia/etiology-of-anemia -
Bone Marrow Failure Syndromes, Overlapping Diseases with a Common Cytokine Signature
International Journal of Molecular Sciences Review Bone Marrow Failure Syndromes, Overlapping Diseases with a Common Cytokine Signature Valentina Giudice 1,2,3 , Chiara Cardamone 1,4 , Massimo Triggiani 1,4,* and Carmine Selleri 1,3 1 Department of Medicine, Surgery and Dentistry “Scuola Medica Salernitana”, University of Salerno, Baronissi, 84081 Salerno, Italy; [email protected] (V.G.); [email protected] (C.C.); [email protected] (C.S.) 2 Clinical Pharmacology, University Hospital “San Giovanni di Dio e Ruggi D’Aragona”, 84131 Salerno, Italy 3 Hematology and Transplant Center, University Hospital “San Giovanni di Dio e Ruggi D’Aragona”, 84131 Salerno, Italy 4 Internal Medicine and Clinical Immunology, University Hospital “San Giovanni di Dio e Ruggi D’Aragona”, 84131 Salerno, Italy * Correspondence: [email protected]; Tel.: +39-089-672810 Abstract: Bone marrow failure (BMF) syndromes are a heterogenous group of non-malignant hemato- logic diseases characterized by single- or multi-lineage cytopenia(s) with either inherited or acquired pathogenesis. Aberrant T or B cells or innate immune responses are variously involved in the pathophysiology of BMF, and hematological improvement after standard immunosuppressive or anti-complement therapies is the main indirect evidence of the central role of the immune system in BMF development. As part of this immune derangement, pro-inflammatory cytokines play an important role in shaping the immune responses and in sustaining inflammation during marrow failure. In this review, we summarize current knowledge of cytokine signatures in BMF syndromes. Keywords: cytokines; bone marrow failure syndromes; aplastic anemia; myelodysplastic syndromes Citation: Giudice, V.; Cardamone, C.; Triggiani, M.; Selleri, C. Bone Marrow 1. -
Myelophthisic Anemia in a Patient with Lobular Breast Carcinoma Metastasized to the Bone Marrow
Open Access Case Report DOI: 10.7759/cureus.3541 Myelophthisic Anemia in a Patient with Lobular Breast Carcinoma Metastasized to the Bone Marrow Muhammad H. Khan 1 , Abdurraoof Patel 1 , Purav Patel 1 , Poras Patel 2 , Elizabeth Guevara 2 1. Internal Medicine, The Brooklyn Hospital Center, Brooklyn, USA 2. Hematology / Oncology, The Brooklyn Hospital Center, Brooklyn, USA Corresponding author: Muhammad H. Khan, [email protected] Abstract Breast tumors have a predilection for metastasizing to the bone leading to cells being displaced by the cancer cells subsequently producing immature leukocytes and erythrocytes in the peripheral blood. We present a case of a 57-year-old female who was found to have myelophthisic anemia secondary to stage four lobular breast carcinoma metastasized to the bone marrow after being misdiagnosed as having thrombotic thrombocytopenia purpura. Diagnosis of myelophthisic anemia requires a thorough workup and treatment is based upon secondary management of the malignancy. Categories: Internal Medicine, Medical Education, Oncology Keywords: ttp, thrombotic thrombocytopenic purpura, adamst13, a disintegrin and metalloproteinase with a thrombospondin type 1 motif (member 13), er, estrogen receptor, pr, progesterone receptor, her2, human epidermal growth factor receptor 2 Introduction Approximately 252,710 new cases of invasive breast cancer were predicted to occur in the United States in 2017. From 2005 to 2014, the incidence of breast cancer among non-Hispanic blacks increased by 0.4% per year [1]. Breast tumors have a predilection for metastasizing to the bone. When metastasis to the bone marrow occurs, cells are displaced by the space-occupying cancer cells and this leads to immature leukocytes and erythrocytes in the peripheral blood [2-3]. -
Hereditary Elliptocytosis CASE REPORT
JMEDS 10.5005/jp-journals-10045-0012Hereditary Elliptocytosis CASE REPORT Hereditary Elliptocytosis 1PS Sharmila, 2Kannupriya, 3MF Paul ABSTRACT Thailand.4 Inheritance of HE is autosomal dominant. Hereditary elliptocytosis (HE) is a group of disorders However, de novo mutations have been reported in rare characterized by the presence of elliptical-shaped erythrocytes cases. on peripheral blood smear. Hereditary elliptocytosis and its related disorders are characterized by clinical, biochemical, CASE REPORT and genetic heterogeneity. Manifestations range from the asymptomatic carrier state to severe, transfusion dependent A 72 years old male presented to our hospital with history hemolytic anemia. Abnormalities of various membrane protein of abdominal pain and loss of appetite for 1 week. There defects contribute to mechanical defects of the erythrocyte was no significant past or family history. He was a non- membrane skeleton. We present a rare case of HE, an alcoholic, vegetarian. No history of any drug therapy. incidental finding without any clinical symptoms related to it. We also discuss on pathophysiology and being. On clinical examination, patient had tenderness at renal, angle. Ultrasonography (USG) examination of abdomen Keywords: Elliptocytes, Erythrocyte, Hemolysis. and pelvis revealed right-sided mild hydronephrosis How to cite this article: Sharmila PS, Kannupriya, Paul MF. and a small calculus in lower one-third of right ureter. Hereditary Elliptocytosis. J Med Sci 2015;1(2):41-43. Thus with these clinical findings, the diagnosis of right Source of support: Nil hydroureteronephrosis with ureteric calculus was Conflict of interest: None made and patient underwent for lithotripsy for ureteric stone. Laboratory investigations included complete INTRODUCTION hemogram, renal function test and liver function test, Hereditary elliptocytosis (HE) and its variants are preoperatively and postoperatively.